NCT06455475View on ClinicalTrials.gov

Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 25, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Diabetic Foot Ulcer
Interventions
OTHER

Derm-Maxx

Derm-Maxx™ Dermal Matrix is an acellular human dermis graft sterilized using the Tutoplast® Tissue Sterilization Process.

Trial Locations (11)

27330

RECRUITING

Premium Foot and Ankle, Sanford

33016

RECRUITING

Bioresearch Partner, Miami Lake

33024

RECRUITING

Royal Research, Hollywood

33175

RECRUITING

Bioresearch Partner, Miami

35611

RECRUITING

North Alabama Research Center, LLC, Athens

43213

RECRUITING

ABC Podiatry, Columbus

44004

RECRUITING

Ohio Foot and Ankle Specialists, Ashtabula

44103

RECRUITING

Cleveland Foot and Ankle Clinic, Cleveland

77478

RECRUITING

Olympus Clinical Research, Sugar Land

89148

RECRUITING

Wahab Research, Las Vegas

91316

RECRUITING

Premium Podiatry, Encino

All Listed Sponsors
lead

Capsicure, LLC

NETWORK